CATAFLAM Sugar Coated Tablets 50mg
Sponsors
Verisfield Single Member S.A.
Conditions
LOW BACK PAIN
Phase 3
A Randomized, Multicenter, Double-Blind, Parallel-Group, Placebo- and Active-Controlled Phase III Therapeutic Superiority Trial Comparing the Efficacy and Tolerability of a Fixed-Dose Combination of Diclofenac + Orphenadrine + Paracetamol to Diclofenac (Cataflam®) and Orphenadrine + Paracetamol (Norgesic®) in Patients with Acute Severe Low Back Pain.
Not yet recruitingCTIS2025-521578-32-00
Target: 224Updated: 2025-09-25
A Randomized, Multicenter, Double-Blind, Parallel-Group, Placebo and Active-Controlled Phase III Therapeutic Superiority Trial Comparing the Efficacy and Tolerability of a Fixed-Dose Combination of Diclofenac potassium + Thiocolchicoside to Diclofenac potassium (Cataflam®) in Patients with Acute Severe Low Back Pain.
Not yet recruitingCTIS2025-523153-33-00
Target: 110Updated: 2026-04-16